Welcome to our dedicated page for CNO Financial Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CNO Financial Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CNO Financial Group's regulatory disclosures and financial reporting.
CNO Financial Group reported an insider transaction by its Chief Investment Officer. On 12/05/2025, the officer surrendered 584 shares of CNO common stock to the company at a price of $40.18 per share. These shares were withheld to cover required tax obligations on previously granted restricted stock units, rather than being an open-market sale.
After this tax-related share surrender, the officer directly beneficially owns 670,958 shares of CNO common stock. The filing is a routine Form 4 disclosure reflecting equity award tax withholding for a senior executive.
CNO Financial Group, Inc. disclosed that its Chief Human Resources Officer, Yvonne K. Franzese, surrendered 475 shares of common stock on 12/05/2025. The shares were returned to the company at a price of $40.18 per share to satisfy required tax withholding on previously granted restricted stock units. After this administrative, tax-related transaction, she directly holds 21,142 CNO shares and indirectly holds 78,279 shares through the Yvonne K. Franzese Revocable Trust. The filing reflects a routine Form 4 insider ownership update rather than an open-market trade.
CNO Financial Group (CNO) reported an insider stock sale by its Chief Human Resources Officer. On 11/24/2025, the officer sold 3,000 shares of common stock at a price of $41 per share, according to a Form 4 filing. After this transaction, the officer directly owned 21,617 shares and indirectly owned 78,279 shares through the Yvonne K. Franzese Revocable Trust.
The filing notes that the shares were sold under a pre-arranged Rule 10b5-1 trading plan that was adopted on August 20, 2025. Such plans allow insiders to sell shares according to preset instructions, helping separate personal trading decisions from nonpublic company information.
CNO Financial Group, Inc. insider reports charitable stock donation
An officer of CNO Financial Group, Inc. (ticker CNO), identified as the President, Worksite Division, reported a charitable donation of company stock. On 11/25/2025, the insider disposed of 1,500 shares of CNO common stock in a transaction coded "G," which denotes a charitable gift, at a reported price of $0 per share. Following this transaction, the insider directly beneficially owns 40,355 shares of CNO common stock. The filing shows no derivative security transactions and indicates the report is filed by one reporting person.
CNO Financial Group has a planned insider sale of up to 3,000 shares of its common stock, with an aggregate market value of $123,000, as disclosed in a Form 144 notice. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 11/24/2025. These securities were acquired from the issuer on 01/02/2024 as 1,800 performance shares and 1,200 shares of restricted stock, both fully paid. Shares of CNO common stock outstanding were 95,353,512 as of the figure reported, which serves as a baseline ownership context.
CNO Financial Group, Inc. CEO and director Gary C. Bhojwani reported a sale of company stock. On 11/20/2025, he sold 31,430 shares of common stock at a weighted average price of $39.9727 per share in an open market transaction coded as a sale. After this transaction, he beneficially owns 227,356 shares directly and 635,471 shares indirectly through the Gary C. Bhojwani Revocable Trust. The filing notes that the shares were sold pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025, with sales executed at prices ranging from $39.49 to $40.465 per share.
CNO Financial Group, Inc. filed a Form 4 reporting a charitable stock donation by its Chief Financial Officer. On 11/20/2025, the CFO disposed of 3,740 shares of CNO common stock in a transaction coded "G," which the filing identifies as a charitable donation at a price of $0 per share. After this transaction, the reporting person directly beneficially owns 195,467.077 shares of CNO common stock. The filing is made by one reporting person and reflects a personal charitable transfer rather than an open-market sale.
A shareholder of CNO (symbol CNO) filed a Form 144 notice indicating an intention to sell 31,430 shares of CNO common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of 1,256,222.53 for the shares to be sold, compared with 95,353,512 shares of common stock outstanding. The shares come from restricted stock acquired on 03/25/2022 and performance shares acquired on 02/14/2023, both issued by the company and marked as not involving separate cash payment. The seller also represents that they are not aware of any undisclosed material adverse information about CNO’s operations.
CNO Financial Group reported an insider stock transaction by its General Counsel. On 11/17/2025, the officer made a charitable donation of 2,000 shares of CNO common stock, recorded with transaction code G and a reported price of $0. After this donation, the officer directly beneficially owns 275,916 shares of CNO common stock. The filing reflects a routine change in ownership rather than an open-market purchase or sale.
CNO Financial Group (CNO) disclosed an insider transaction by its Chief Investment Officer. On 11/10/2025, the executive exercised 71,400 employee stock options at an exercise price of $17.38 per share and then sold 48,665 shares at a $41.2414 weighted average price to cover the exercise price and required taxes. Following these transactions, the executive beneficially owned 671,542 shares directly. The options relate to grants that vested on 02/23/2018 and 02/23/2019 and expire on 02/23/2026. Sales occurred between $41.00 and $41.57 per share.